Investigation launched into Select Medical's $16.50/share acquisition over potential board conflicts.

Bleichmar Fonti & Auld LLP is investigating Select Medical Holdings Corporation's board and senior management for possible breaches of fiduciary duty related to the company's pending sale at $16.50 per share. The acquisition involves insiders allowed to rollover shares, a benefit not extended to public shareholders. The investigation questions the fairness of the deal and the board's disclosures ahead of the June 26 shareholder vote. Shareholders may have legal options and are encouraged to seek more information from the law firm.